Introduction
Signaling through the Notch receptors regulates the development and differentiation of a wide variety of cell types and tissues. A single Notch gene has been found in Drosophila, while two Notch homologs are present in Caenorhabditis elegans and four in vertebrates (Fig. 1) . A similar increase in complexity occurred with the Notch ligands, which are divided into two families in vertebrates, Deltalike1 (Dll1), Dll3 and Dll4 and Jagged1 (Jag1) and Jag2 (reviewed in Artavanis-Tsakonis et al. (1999) , ). When Notch is activated by ligand binding, it undergoes a series of proteolytic cleavages that release the intracellular domain or ICD (Kopan et al., 1996; Schroeter et al., 1998; , this domain translocates to the nucleus in a complex with a CSL transcription factor and activates the expression of downstream target 0925-4773/$ -see front matter Ó 2011 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2011.02.002 genes (Jarriault et al., 1995 (Jarriault et al., , 1998 Lu and Lux, 1996; Iso et al., 2001; Ong et al., 2006) .
Genetic studies indicate that the four murine Notch receptors possess distinct functions during development (Swiatek et al., 1994; Conlon et al., 1995; Hamada et al., 1999; Huppert et al., 2000; Moloney et al., 2000; McCright et al., 2001; Krebs et al., 2003; Cheng et al., 2007) . In mammals, an overlap in the temporal and spatial expression of both the Notch receptors and their ligands in the same cells and tissues predict an additional layer of regulation in order to produce differential developmental outcomes (Franco Del Amo et al., 1992; Lardelli and Lendahl, 1993; Williams et al., 1995; Johnson et al., 2001) . In these developing tissues, it has been shown that specific ligand-Notch receptor pairs can regulate developmental outcomes. For example, naïve CD4 cells must make a binary lineage decision to become either Th1 or Th2 cells. Jagged activation of Notch1 or Notch2 induces Th2 (Amsen et al., 2004 ) and Dll1 activation of Notch3 induces Th1 (Maekawa et al., 2003; Amsen et al., 2004) . Similarly, during kidney development both Notch1 and Notch2 are expressed in the developing nephron, however Jagged1 mediated activation of Notch2 is necessary for the development of podocytes and proximal convoluted tubules and Notch1 cannot substitute for this function (Cheng et al., 2007) . Since the Notch receptors overlap with the ligands in expression in these cells and tissues, these data indicate that there is an additional layer of control of Notch activity by modifiers of the pathway that regulates the biological outcome of Notch receptor activation.
The cytoplasmic protein, Numb is an essential cell fate determinant during neural development (Rhyu et al., 1994; Guo et al., 1996; Verdi et al., 1996 Verdi et al., , 1999 Zhong et al., 1996 Zhong et al., , 1997 Zilian et al., 2001; Petersen et al., 2002 Petersen et al., , 2004 Huang et al., 2005; Kuo et al., 2006) . Numb is an adaptor protein, it binds to the intracellular domain (ICD) of Notch1 and then recruits the E3 ubiquitin ligase, Itch, to the complex (Verdi et al., 1996; Dho et al., 1999; Qiu et al., 2000; McGill and McGlade, 2003) . Itch, in turn, polyubiquitinates Notch1ICD leading to its degradation by the proteasome (Wakamatsu et al., 1999; Qiu et al., 2000; McGill and McGlade, 2003; Chastagner et al., 2008; McGill et al., 2009) . Recent studies of Notch1 in C2C12 cells has shown that this receptor recycles from the cell surface constitutively, and in the presence of Numb, it is redirected to an endocytic compartment for degradation (McGill et al., 2009) .
Mammals have a single Numb gene that produces four protein isoforms by alternative splicing, Numbp65 (Nbp65), Nbp66, Nbp71 and Nbp72 (Fig. 1) . These isoforms are generated by alternate splicing of two exons, the first is found in the phosphotyrosine binding domain (PTB) and a second larger exon is found in the proline rich region (PRR) of Numb ( Fig. 1 ; Dho et al., 1999; Verdi et al., 1999) . The function of the Numb isoforms remains unclear during development. It has been reported that Numb proteins with short PTB domains (PTB S ) enhanced the differentiation of PC12 cells in response to nerve growth factor (NGF) (Pedersen et al., 2002) . In other studies, Numb proteins with the short form of the PRR (PRR S ) promoted the differentiation of neural crest stem cells, while the long form (PRR L ) promoted their proliferation (BaniYaghoub et al., 2007) . Further, differentiation of exocrine and endocrine cells in the developing pancreas is dependent on the expression of the PRR L and PRR S , respectively (Yoshida et al., 2003) . Both of these cell lineages are derived from the pancreatic duct, which expresses Notch2, but not Notch1 (Lammert et al., 2000) . Most studies have used Notch1 as the target to assess the functional consequences of interactions between Notch and individual Numb proteins (Qiu et al., 2000; Conboy and Rando, 2002; McGill and McGlade, 2003; Anderson et al., 2005; McGill et al., 2009 ). However, it is possible that some of the discrepancy in the reported functions of particular Numb isoforms may relate to differences in their interactions with specific Notch receptors.
The regulation of proliferation and differentiation of myogenic progenitor cells is a powerful model to examine the differential function of the Notch receptors. During embryonic myogenesis, Notch1-3 and Numb are expressed in both distinct and overlapping patterns within the somites in the dermomyotome and myotome (Dho et al., 1999 ; Verdi et al., Numb gives rise to four proteins by alternative splicing of a single transcript. The longest Numb isoform, Nbp72, has both alternative exons. Both Nbp71 and Nbp65 lack the first alternative exon found in the phosphotyrosine binding domain (PTB), it encodes 11 amino acids. The second alternative exon encodes a 48 amino acid addition to the proline rich region (PRR) and this is spliced out of Nbp65 and Nbp66. The four Numb protein isoforms are as diagrammed, numbers above the lines refer to amino acids. (B) Notch receptors are heterodimeric transmembrane proteins. The extracellular domain consists of a series of conserved EGF repeat units that are glycosylated. Notch1 and Notch2 have 36 tandem EGF repeats, Notch3 has 34 and Notch4 has 28. Immediately C-terminal to the EGF repeats are 3 NotchLin12 repeats (LIN). The intracellular domain has a RAM domain that is a protein-protein interaction domain adjacent to the transmembrane domain. Notch1-3 have six ankyrin repeat domains (Ank R ) flanked by nuclear localization sequences (NLS), but Notch4 has only five repeats. The C terminus of the Notch receptors is more divergent, however all have a PEST sequence.
1999; Wakamatsu et al., 1999; Qiu et al., 2000; Krebs et al., 2003; Hansson et al., 2004; Holowacz et al., 2006) . Studies using C2C12 myoblasts or 10T1/2 cells have demonstrated that Notch1 and Notch2 are negative regulators of myogenesis (Reaume et al., 1992; Kopan et al., 1994; Shawber et al., 1996; Jarriault et al., 1998; Wilson-Rawls et al., 1999; Yoshida et al., 2003) . Our current studies examine Numb isoform-specific regulation of Notch1-3ICD. Our data predicts that Numb differentially targets the intracellular domains of the Notch receptors. These observations are the first to demonstrate that Notch1 is the preferential cellular target of Numb and that Notch3 is not inhibited by Numb.
Results

Numb isoforms differentially inhibit NotchICD mediated transcription
Activated Notch (NotchICD) up-regulates transcription of target genes by binding to CSL sites in a complex with CSL co-factors, such as RBPj (Jarriault et al., 1995; Ong et al., 2006) . In order to examine the ability of specific Numb isoforms to inhibit transactivation of target genes by Notch1-3ICD, transcription assays were done using the 4XCSL-Luciferase reporter that has four identical high affinity CSL binding sites driving expression of Luciferase (kind gift of R. Kopan and R. Kageyama). The Notch receptors vary in their ability to up-regulate expression of specific target genes (Shimizu et al., 2002; Ong et al., 2006) , therefore initial experiments were performed to determine the amount of each NotchICD expression plasmid that was necessary to achieve similar levels of activation of the reporter gene (data not shown). We then determined the ability of each Numb isoform to inhibit Notch1-3ICD mediated transactivation of the 4XCSL-Luciferase reporter gene. 3T3 cells were transfected with the 4XCSL-Luciferase reporter, a specific CS2+NotchICD plasmid and a plasmid that expressed Nbp65, Nbp66, Nbp71 or Nbp72 (pCDNA3.1-Nb). At 24 h post-transfection the Luciferase activity in cell lysates was determined. Data presented are the result of three independent experiments done in triplicate. Consistent with previous observations, the Luciferase activity induced by Notch1ICD was inhibited significantly by all four Numb isoforms ( * p < 0.05) (Fig. 2; McGill and McGlade, 2003) . In contrast, reporter gene activation by Notch2ICD was differentially affected; Nbp72, Nbp66 and Nbp71 all significantly inhibited Notch2ICD, while Nbp65 had no significant effect. Interestingly, Luciferase activity induced by Notch3ICD was not inhibited by any of the Numb isoforms (Fig. 2) .
Numb variably relieves Notch mediated inhibition of myogenesis
To examine the biological significance of Notch/Numb interactions we took advantage of the ability of C3H10T1/2 cells to differentiate into muscle. Exogenous expression of MyoD in 10T1/2 fibroblasts will induce myogenesis; the cells will exit the cell cycle, fuse into multinucleated myotubes and express muscle contractile proteins, such as myosin heavy chain (MHC). Previous work has shown that MyoD-induced myogenic conversion can be inhibited by activated Notch1 or Notch2 Nye et al., 1994; Shawber et al., 1996; Jarriault et al., 1998; Wilson-Rawls et al., 1999) , but there were no data regarding Notch3 in this assay. We asked whether Numb proteins could block NotchICD mediated inhibition of MyoD induced myogenic conversion of C3H10T1/2 cells. Transiently transfected 10T1/2 cells were cultured in differentiation medium and examined by immunohistochemistry (IHC) using the MY-32 monoclonal antibody to detect MHC positive multinucleated myotubes. The data in Table 1 are expressed as percent of MyoD and are the result of three experiments done in duplicate ±SD. Consistent with previous reports, Notch1ICD and Notch2ICD significantly inhibited MyoD induced myogenesis. Interestingly, Notch3ICD also significantly inhibited myogenesis also (Table 1 ). All four Numb isoforms relieved Notch1ICD inhibition of MyoD significantly, resulting in increased numbers of MHC positive multinucleated myotubes (Table 1) . Notch3ICD was not inhibited by any of the Numb proteins, which is also consistent with the transactivation data (Table 1) . Interestingly, Notch2, which was significantly inhibited by Nbp66, Nbp71 and Nbp72 at the transcriptional level, was not affected significantly in the myogenesis assay by any Numb isoform (Table 1 and Fig. 2 ).
2.3.
Numb isoforms bind to the intercellular domain of all three Notch receptors Numb has been reported to bind to Notch1, then it recruits the E3 ligase, Itch, to the complex (McGill and McGlade, 2003; McGill et al., 2009 ). The differential ability of the Numb proteins to inhibit the Notch receptors could be due to their inability to form a stable complex with Notch2 or Notch3. In order to determine if the Numb proteins can form complexes with all three Notch receptors, co-immunoprecipitation experiments were performed with Myc-tagged Notch1-3ICD co-transfected into 293T cells with all four Numb isoforms. Immunoprecipitations from total protein lysates were done using an anti-Myc antibody and the blots were probed with an anti-pan-Numb antibody. Cells transfected with Notch1-3ICD-Myc all co-precipitated the Numb proteins (Fig. 3 ). These data indicate that both Notch2ICD and Notch3ICD can form complexes with the Numb proteins, therefore the differential effect of Numb on these receptors is not due to an inability of Numb protein isoforms to bind to the different Notch intracellular domains. When cell lysates were probed using an anti-pan-Numb antibody, the Numb proteins were detected in transfected 293T cells (Fig. 3B ).
ClustalW comparison of the murine Notch1-3ICDs
Ubiquitin (Ub) is covalently added to lysine (K) residues in target proteins by E3 Ub ligases, such as Itch, and Numb promotes Itch mediated ubiquitination of Notch1 (Hershko and Ciechanover, 1992; McGill and McGlade, 2003; Chastagner et al., 2008) . It is possible that amino acid sequence divergence in the ICD of the Notch proteins can result in inefficient ubiquitination of these domains. The mammalian Notch receptors arose through gene duplication and structurally the proteins are not identical, with Notch3 being more diverged from Notch1 and Notch2 (Franco del Amo et al., 1992; Hansson et al., 2004;  Fig. 1 ). To determine if there is a significant change in the number or placement of potential donor lysines within the ICD regions of Notch1-3 we carried out a ClustalW analysis of the murine Notch amino acid sequences (Fig. 4) . The alignment derived from the ClustalW analysis demonstrates that the number and location of lysines are conserved except for a region near the C terminal end of the ICD (Fig. 4) . Notch1 has 26 lysines in the ICD and 21 of these residues are conserved in Notch2, whereas only 15 are conserved in Notch3. In fact, a subdomain (residues 2152-2184) of the Notch1ICD shows little conservation with this same region of Notch2 and Notch3. In Table 1 -Numb relieves Notch1ICD mediated inhibition of MyoD induced myogenesis. 10T1/2 cells were transfected as described and cells were cultured in differentiation medium for 5 days, fixed and immunohistochemistry was done with anti-myosin heavy chain antibody. Multinucleated myosin heavy chain positive myotubes were counted in 10 random fields per plate and expressed as percent of MyoD only. All data are the result of three experiments done in duplicate. * p < 0.05. spite of this, six lysines are conserved between Notch1 and Notch2, while only three lysine residues are present in Notch3ICD. This raises the possibility that a reduction in the number of available lysine residues may make Notch3ICD less susceptible to ubiquitination. However, this does not explain the differential regulation of Notch1 and Notch2, which have a similar pattern of lysines in this region.
Notch3ICD is not polyubiquitinated
Nbp66 promotes Itch mediated ubiquitination of Notch1-ICD and targets it to the proteasome (McGill and McGlade, 2003; McGill et al., 2009 ). To test whether Notch3ICD was a good target for ubiquitination as compared to Notch1ICD, 293T cells were transfected with Nbp66, Notch1ICD-Myc or Notch3ICD-Myc, and HA-tagged Ub and were cultured in the presence or absence of the proteasome inhibitor MG132. Cell lysates were immunoprecipitated with an anti-Myc antibody and blots were probed with an anti-HA antibody to detect ubiquitinated Notch proteins. As can be seen in Fig. 5 , in the absence of MG132, little ubiquitinated Notch1ICD was detected, consistent with previous reports that indicate it is rapidly degraded (Qiu et al., 2000; McGill and McGlade, 2003; Chastagner et al., 2008; McGill et al., 2009 ). In the presence of the proteasome inhibitor MG132, a smear of polyubiquitinated Notch1ICD bands was detected, more so in the presence of Nbp66. Notch3ICD was present as a single band in either condition, indicating that it is not polyubiquitinated. When the blot was stripped and reprobed with the anti-Myc antibody (Fig. 5) , Notch3 was present as a doublet indicating that Notch3ICD is likely monoubiquitinated, it could be multiubiquitinated but this seems unlikely as we only detected the two bands ( Supplementary Fig. 1 ). A single band was detected for Notch1ICD. The anti-Myc antibody does not recognize the higher molecular weight polyubiquitinated forms of Notch1ICD on Western blots, likely due to epitope masking or steric hindrance.
To determine the region of Notch1ICD that was a target for Numb binding, a series of Myc-tagged truncation mutants were cloned as described in Fig. 6 . These truncation mutants were co-expressed in 293T cells with Nbp72 and Nbp66. Cell lysates were immunoprecipitated using the anti-Myc antibody and blots were probed with the anti-pan Numb antibody. Full length Notch1ICD co-precipitates Nbp72 and Nbp66, as expected. When Nbp72 and Nbp66 were co-transfected with the truncation mutants of Notch1, only residues 2056-2184 Fig. 4 -ClustalW alignment of NotchICD sequences. Notch amino acid sequences for various vertebrate and invertebrate taxa were compiled from the NCBI GenBank database. After regions of low conservation were further aligned with use of vertebrate comparisons only, significant sequence alignment is shown for mouse Notch1-3ICDs. Lysine residues (K), which are potential targets for ubiquitin ligation, are highlighted to show their relative conservation among the three NotchICDs. At the right, amino acid residue counts reflect their positions in the overall protein sequence. The region of highest lysine density, and the least overall amino acid sequence conservation is found in Notch1ICD2139-2184 and the aligned regions of Notch2ICD and Notch3ICD.
(NS4) also bound both Numb proteins (Fig. 7) . From the ClustalW analysis, we find that this 129 amino acid subdomain includes the highest density of lysines, there are 12 lysines in this region of Notch1, 11 and 7 of these lysines are conserved in the homologous Notch2 and Notch3 regions, respectively (Fig. 4) . Therefore, the high number of lysines in this small region of Notch1 may increase the efficiency of ubiquitination mediated by Numb and the loss of five of these residues may explain the lack of regulation of Notch3.
To determine if a change in the number of lysine residues would alter the polyubiquitination of Notch1, a Notch1/ Notch3 chimeric protein was created that consists of Notch1ICD sequences from 1744 to 2055 and Notch3 residues 1972 to 2097 that are homologous to Notch1 2056 to 2184. 293T cells were transfected with plasmids expressing HAUb, Nbp66 and the Notch1/3 chimeric protein and cell lysates were immunoprecipitated with an anti-Myc antibody and blots probed with an anti-HA antibody to detect ubiquitinated forms of the Notch1/3 protein. Unlike Notch1ICD which demonstrates an increasing number of slower migrating forms due to increased ubiquitination in the presence of MG132, the Notch1/3 hybrid demonstrates a single HA positive band (Fig. 8) with or without MG132. When co-expressed with Nb in the presence or absence of MG132, Notch3ICD and the Notch1/3 hybrid proteins are both stable, however Notch1 is much reduced unless the transfected cells are treated with MG132 (Fig. 8B) . These data indicate that a lack of lysine residues allows Notch3 to evade Numb mediated degradation. Notch1ICD is diagrammed with the six ankyrin repeats, the RAM domain, the 7 * indicates the partial ankyrin repeat that is C-terminal to this domain. NS1-NS4 are similar in size, the numbers on either side represent the amino acid position relative to the entire Notch1 protein. All truncation mutants were cloned with a Myc epitope tag at the C-terminus. 
Discussion
Our data demonstrate a novel observation, that the Notch receptors are not equivalent targets for Numb mediated ubiquitination and degradation in cell culture. In transcription assays, all four Numb isoforms effectively targeted Notch1ICD, but Notch2ICD was variably targeted, with the PTB L -containing isoforms, Nbp66 and Nbp72, being the most effective, and Notch3ICD was not inhibited. In the myogenesis assays, Notch1 was inhibited by all four Numb isoforms, Notch2 was not affected significantly, and Notch3 was unaffected (Fig. 2 and Table 1 ). ClustalW analysis indicated that the loss of a number of conserved lysine residues in Notch3ICD was significant, and our data indicated that a lack of these residues makes it a poor target for ubiquitination. Importantly, these studies predict that Notch3ICD is not a target of Numb-induced ubiquitination. This is a novel finding; differential targeting of Notch receptors has not been reported for Numb. Numb does discriminate among the three mammalian Gli proteins, (Gli1-3) that are mediators of Hedgehog signaling, and Numb specifically mediates ubiquitination of Gli1, but not Gli2 or Gli3 (DiMarcotullio et al., 2006) . While Notch2 was inhibited by Numb in transcription assays, it was not significantly affected in the myogenesis assay. This may be due to sensitivity, as Notch2 does not inhibit myogenesis as robustly as Notch1 or Notch3. Interestingly, while others have found that different isoforms of Numb had different roles, we found that all four proteins could inhibit Notch1 and none affected Notch3.
Generally, proteasomal degradation is initiated by the presence of polyubiquitin; the initial Ub monomer that is added to a lysine residue in a target protein is extended with multiple Ub monomers thus forming long chains (polyUb) (Kopan et al., 1996) . Notch1 is modified by Numb and Itch with polyUb (McGill and McGlade, 2003; Chastagner et al., 2008; McGill et al., 2009) , and this was demonstrated by the ladder of slower migrating forms in the presence of the proteasome inhibitor MG132 (Fig. 5 and Supplementary Fig. 1 ). The N terminus of the ICD contains two domains that are known to be important for protein-protein interactions, the RAM domain and six conserved ankyrin repeat domains ( Fig. 1) (Kopan et al., 1996; Artavanis-Tsakonis et al., 1999; . Previously, the RAM and ankyrin domains have been implicated as the target sites for ubiquitination by Itch (Petersen et al., 2004) . Truncation mutants of the Notch1ICD demonstrated that a single region, Notch1ICD 2056-2184, formed a complex with Nbp66/72 (Fig. 7) . The ClustalW analysis demonstrated that this region of the ICD domain has a high density of lysine residues but the overall amino acid sequence of this region was not highly conserved among the three Notch receptors. The homologous region in the Notch3ICD has significantly fewer lysine residues (Fig. 4) and when this region was substituted for Notch1ICD 2056-2184 Notch1 was no longer polyubiquitinated. Therefore, both our sequence alignment and analyses of this region indicate that a reduced number of lysine residues in this domain of Notch3 makes it a poor target for the Numb/Itch complex. The homologous region of Notch2 had fewer lysines, but not significantly, and their loss cannot explain the differential targeting by the Numb isoforms in transcription assays.
There are other types of Ub modification of proteins, monoUb, in which a single Ub modification is added and multiUb in which several lysine residues have Ub monomers added. These modifications are associated with protein endocytosis and receptor recycling and down-regulation. This has been found with receptor tyrosine kinases such as EGFR (Mukhopadhyay and Riezman, 2007) . Recent data has demonstrated that Notch1 recycles to and from the plasma membrane in C2C12 myoblasts and the presence of Numb alters its path to the lysosome (McGill et al., 2009) . Our experiments indicate that Notch3 was monoUb, or possibly multiUb, and this modification did not alter its function (amino acids 1977-2097) . A. Cells were transfected with the Notch1/3 chimera, HA-Ub and Nbp66, lysates were blotted with an anti-HA antibody. In the presence or absence of MG132 Notch1/3 is present as a single band indicating that Notch1/3 is not polyubiquitinated. (B) 293T cells were transfected with N1ICD, N1/3ICD or N3ICD and Numb in the presence or absence of MG132. The blot was probed with anti-Myc antibody. The N1/3ICD and N3ICD proteins are stable in the absence of MG132, unlike N1ICD (note starred lanes).
nor cause its degradation (Figs. 2, 4 and Table 1 ). Perhaps, only having monoUb causes Notch3 to be recycled but not degraded, and this may be essential to its function. Alternatively, it is not a target for Itch and is ubiquitinated by other E3 ligases that do not rely on Numb. There is also a recent report that Notch3 is not degraded by the proteasome (Jia et al., 2009) .
Previous studies have revealed a temporally and spatially dynamic pattern of Notch1-3 expression during early embryonic events in skeletal muscle differentiation. Notch1 and Notch2 can inhibit muscle differentiation Shawber et al., 1996; Wilson-Rawls et al., 1999; Hansson et al., 2004) , and our data demonstrated that Notch3 also inhibits MyoD induced myogenesis (Table 1) . Numb has been shown to regulate asymmetric divisions during muscle development in flies and mice (Carmena et al., 1998; Park et al., 1998; Han and Bodmer, 2003; Venters and Ordahl, 2005; Holowacz et al., 2006) . During somitogenesis, skeletal muscle is derived from progenitor cell populations located in the dermomyotome. These cells become committed to the myogenic lineage upon delamination from the dorsomedial (DML) and dorsolateral (DLL) lips of the dermomyotome and enter into the myotome or migrate out into the limbs or body wall. Studies have shown that Numb is expressed in the cells of the myotome and cells of the DML and DLL that are dividing in a plane such that one daughter will migrate into the myotome (Venters and Ordahl, 2005; Holowacz et al., 2006) . Individual Notch receptors demonstrate both unique and overlapping expression patterns during somite differentiation (Conlon et al., 1995; Williams et al., 1995) . Notch1 is expressed in the presomitic mesoderm (PSM) and throughout new somites and becomes restricted to the dorsomedial region of the somite as it matures. Notch2 transcripts are limited to the presomitic mesoderm (Williams et al., 1995; Hamada et al., 1999) . Notch3 is not expressed in the PSM, but is expressed throughout newly formed somites and is subsequently restricted to the dorsal regions of the dermomyotome as the somite matures (Williams et al., 1995) . The complex nature of Notch/Numb interactions in small populations in the embryo makes it very difficult to effectively assess the outcomes of their interaction in vivo. We have been able to exploit cell culture systems that capture more static events to clearly demonstrate the potential for differential regulation. This has lead to a model of myogenic differentiation that would be consistent with these observations; Notch1 and Numb interact in those cells that are dividing in the dorsomedial and dorsolateral lips of the dermomyotome and this interaction would govern the decision of one daughter cell to enter the myoblast lineage and the myotome. Based on our data and its expression pattern, the role of Notch3 in the complex signaling milieu of the somite is to maintain a proliferating population of cells in the dermomyotome that can be recruited to any of the somitic lineages. Our data predicts that while Numb can inhibit Notch2 significantly in transcription assays, it had no effect during myogenesis; so the interaction between Notch2 and Numb is functionally unclear.
4.
Experimental procedures
Plasmids
The Notch1-3ICD proteins were expressed from pCS2-NotchIC-Myc Tag (MT) vectors. These plasmids and the 4XCSL-Luciferase reporter gene were kind gifts of R. Kopan (Washington University). The mouse Notch2ICD, kind gift of K. Loomes (Children's Hospital of Philadelphia), was cloned into the pCS2-MT backbone. The four alternatively spliced mouse Numb isoforms were cloned into pCDNA3.1 and were the kind gifts of J. McGlade (University of Toronto). Notch1 truncation mutants were synthesized by PCR and cloned into pCS2-MT. The mouse full-length Notch1ICD protein consists of amino acids 1744-2184, the truncation mutants consist of amino acids 1744-1864, 1847-1967, 1953-2072 or 2055-2184 . The Notch1/Notch3 chimera was constructed using Notch1-ICD sequences from 1744 to 2055 and cloning in frame Notch3 sequence that is homologous to 2055-2184. The pRK5-HA-Ub vector was a kind gift of T.M. Dawson (Johns Hopkins University). All plasmids were confirmed by sequencing.
4.2.
Transcription assays NIH3T3 mouse fibroblasts were plated at 7.0 · 10 6 cells/mL in 24-well plates and grown in Dulbecco's modified Eagle's medium (DMEM) (MediaTech, Inc., Manassas, VA) supplemented with 10% newborn calf serum (NCS). Cells were transfected 24 h later in serum free DMEM using Lipofectamine with Plus Reagent (Invitrogen, Carlsbad, CA). Cells were transfected with 0.1 lg 4XCSL Luciferase, 0.025 lg of Notch1IC, 0.05 lg of Notch2IC or 0.0125 lg of Notch3IC. All transfections that included a Numb protein were done with 0.05 lg pCDNA3.1-Numb plasmid. All transfections included 0.05 lg of pCMV-eGFP (Invitrogen, Carlsbad, CA). Total plasmid DNA was kept constant in all transfections by the addition of empty vector. At 48 h post-transfection cell lysates were prepared using lysis buffer from Promega's Luciferase Assay System (Promega, Madison, WI) according to the manufacturer's protocol. Luciferase activity was detected on a FLX800 Biotek plate reader (Biotek Instruments, Winooski, VT) and samples were normalized to GFP expression. All data are the mean ± SD. of duplicate samples done in triplicate, and statistical significance was determined using a one-way ANOVA. Optimization was done as above, but using a range of input CS2 + NotchICD plasmids from 0.01 to 150 lg was used for transfection. Total input DNA was maintained using empty CS2 + vector. The NICD concentration that elicited the optimal luciferase activity for each Notch was subsequently used.
Co-Immunoprecipitation and MG132 treatment
HEK293T cells were plated 24 h prior to transfection in 35 mm dishes at a density of 3.0 · 10 7 cells/mL in DMEM supplemented with 10% fetal bovine serum (FBS). For immunoprecipitation (IP) cells were transfected with a total of 2 lg of plasmid DNA using Lipofectamine with Plus reagent as above. To inhibit the proteasome, MG132 (Sigma-Aldrich, St. Louis, MO) was dissolved in DMSO and added at a final concentration of 50 lM to the medium 4 h prior to cell lysis. Controls with vehicle only had the equivalent volume of DMSO added to the medium. The medium was changed to DMEM with 10% FBS at 3 h post-transfection. Cells were harvested 24 h post-transfection and lysed in 300 lL of cold NTT lysis buffer (140 mM NaCl, 50 mM Tris, pH 7.5, 1 mM DTT, 1 mM EDTA, 0.1% Triton X-100, 10% glycerol) containing Complete protease inhibitor cocktail (Roche Applied Scientific, Indianapolis, IN). Lysates were spun at 14,000 rpm at 4°C for 15 min to remove cellular debris. The IP of the lysate was done using 30 lL of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology, Santa Cruz, CA) with 1 lg of the monoclonal anti-c-Myc 9E10 (Santa Cruz Biotechnology, Santa Cruz, CA). Samples were rotated at 4C overnight and washed in NTT buffer. The proteins were boiled in 2· Laemmli sample buffer and separated on 8% or 12% sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE). For Western blots, the proteins were transferred using the Bio-Rad semidry transfer system to Immobilon-P membrane in BS-N transfer buffer (48 mM Tris, 39 mM glycine, 0.0375% SDS) at 15 V for 20 min. Membranes were blocked overnight at 4°C in 20 mM pH7.5 Tris-buffered saline containing 0.05% Tween 20 (TBS-T) with 2% Carnation nonfat dry milk. The proteins were detected using a pan-Numb antibody or the anti-HA antibody 12CA5 (Invitrogen, Carlsbad, CA) and the anti-mouse-AP antibody (Invitrogen, Carlsbad, CA) using the ECL substrate (GE Healthcare Biosciences Corp., Piscataway, NJ) and Molecular Dynamics (Piscataway, NJ) Storm fluorimeter. Images were altered for contrast so that all had a similar background.
C3H10T1/2 fibroblast cell myogenic conversion assay
Myogenic conversion assay was performed as previously described (Wilson-Rawls et al., 1999) . Briefly, 7.0 · 10 6 C3H10T1/2 cells were seeded onto gelatinized plates in DMEM with 10% FBS. Cells were transfected at seeding using Fugene6 and a total of 2 lg of plasmid DNA at a 1:3 DNA:reagent ratio (Roche Applied Scientific, Indianapolis, IN), the total DNA concentration was made equal in all transfections by the addition of empty vector DNA. Cells were changed to differentiation medium at 24 h post-transfection, and the medium was changed daily for 5 days. Cells were fixed in cold methanol at À20°C, and immunohistochemistry (IHC) was done to detect myosin heavy chain (MHC) using the monoclonal MY-32 antibody (Sigma-Aldrich, St. Louis, MO) and the histostain SP colorimetric detection kit (Zymed-Invitrogen, Carlsbad, CA) and were counterstained with hematoxylin. MHC positive multinucleated myotubes were counted 10 random fields/35 mm dish at 100·. The data are expressed as percent of MyoD. All experiments were duplicates done in triplicate and statistical analysis was done using the Student's T test.
4.5.
Comparative Notch amino acid sequence analysis
The number of Notch genes varies across a diverse set of taxa (Artavanis-Tsakonis et al., 1999; Hansson et al., 2004) . A comparative species evolutionary analysis of Notch amino acid sequences was conducted using only sequence following the proteolysis point that marks the N-terminus of the ICD (amino acid 1744 in Notch1). Patterns of amino acid evolutionary change were examined to determine if there are ICD regions in Notch1 that are not conserved in Notch2 and Notch3 and which may be candidate sites for ubiquitination. Notch amino acid sequences available in GenBank (www.ncbi. nlm.nih.gov) from various vertebrate and invertebrate species were aligned using a standard ClustalW analysis (www.clus tal.org; Larkin et al., 2007) . The inclusion of such distantly related taxa (e.g., human, zebrafish, Drosophila, urchin and chicken) was informative for initial sequence alignment, and significant conserved sequence regions could be identified. However, the vast evolutionary divergence among some of these taxa can result in sequence regions that show very little, if any, conservation due to lineage-specific and Notchspecific differences in function (i.e., Notch receptors and their domains may function differently across very divergent taxa). Thus after initial alignment, only vertebrates were included to remove large regions of ''gaps'' in alignment (20-50 residues) that showed no significant resolution in the ClustalW analysis. The result of this final analysis is shown in Fig. 3 , with only mouse Notch1-3ICD alignments for simplification.
